nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2E1—Fingolimod—multiple sclerosis	0.209	0.274	CbGbCtD
Trimethadione—CYP2E1—Mitoxantrone—multiple sclerosis	0.0983	0.129	CbGbCtD
Trimethadione—CYP3A4—Fingolimod—multiple sclerosis	0.0634	0.0829	CbGbCtD
Trimethadione—CYP2C19—Prednisone—multiple sclerosis	0.0512	0.067	CbGbCtD
Trimethadione—CYP2E1—Dexamethasone—multiple sclerosis	0.051	0.0667	CbGbCtD
Trimethadione—CYP3A4—Methylprednisolone—multiple sclerosis	0.0408	0.0534	CbGbCtD
Trimethadione—CYP2C8—Dexamethasone—multiple sclerosis	0.0381	0.0498	CbGbCtD
Trimethadione—CYP2C19—Dexamethasone—multiple sclerosis	0.0319	0.0418	CbGbCtD
Trimethadione—CYP3A4—Triamcinolone—multiple sclerosis	0.0309	0.0405	CbGbCtD
Trimethadione—CYP3A4—Mitoxantrone—multiple sclerosis	0.0298	0.039	CbGbCtD
Trimethadione—CYP2C9—Dexamethasone—multiple sclerosis	0.0266	0.0348	CbGbCtD
Trimethadione—CYP3A4—Betamethasone—multiple sclerosis	0.0266	0.0347	CbGbCtD
Trimethadione—CYP3A4—Prednisolone—multiple sclerosis	0.0262	0.0343	CbGbCtD
Trimethadione—CYP3A4—Prednisone—multiple sclerosis	0.0247	0.0324	CbGbCtD
Trimethadione—CYP3A4—Dexamethasone—multiple sclerosis	0.0154	0.0202	CbGbCtD
Trimethadione—Leukopenia—Fingolimod—multiple sclerosis	0.00167	0.00752	CcSEcCtD
Trimethadione—Eosinophilia—Cladribine—multiple sclerosis	0.00151	0.00677	CcSEcCtD
Trimethadione—Pancytopenia—Cladribine—multiple sclerosis	0.00144	0.00649	CcSEcCtD
Trimethadione—Neutropenia—Cladribine—multiple sclerosis	0.00142	0.00639	CcSEcCtD
Trimethadione—Paraesthesia—Fingolimod—multiple sclerosis	0.00137	0.00616	CcSEcCtD
Trimethadione—Fatigue—Fingolimod—multiple sclerosis	0.00132	0.00591	CcSEcCtD
Trimethadione—Hiccups—Prednisolone—multiple sclerosis	0.00131	0.00588	CcSEcCtD
Trimethadione—Epistaxis—Cladribine—multiple sclerosis	0.00128	0.00575	CcSEcCtD
Trimethadione—Haemoglobin—Cladribine—multiple sclerosis	0.00122	0.0055	CcSEcCtD
Trimethadione—Haemorrhage—Cladribine—multiple sclerosis	0.00122	0.00547	CcSEcCtD
Trimethadione—Hiccups—Triamcinolone—multiple sclerosis	0.0012	0.0054	CcSEcCtD
Trimethadione—Hiccups—Methylprednisolone—multiple sclerosis	0.0012	0.00539	CcSEcCtD
Trimethadione—Pancytopenia—Azathioprine—multiple sclerosis	0.00117	0.00528	CcSEcCtD
Trimethadione—Erythema multiforme—Cladribine—multiple sclerosis	0.00115	0.00517	CcSEcCtD
Trimethadione—Asthenia—Fingolimod—multiple sclerosis	0.00109	0.00492	CcSEcCtD
Trimethadione—Hiccups—Betamethasone—multiple sclerosis	0.00109	0.0049	CcSEcCtD
Trimethadione—Hiccups—Dexamethasone—multiple sclerosis	0.00109	0.0049	CcSEcCtD
Trimethadione—Pruritus—Fingolimod—multiple sclerosis	0.00108	0.00485	CcSEcCtD
Trimethadione—Alopecia—Cladribine—multiple sclerosis	0.00108	0.00483	CcSEcCtD
Trimethadione—Agranulocytosis—Azathioprine—multiple sclerosis	0.00103	0.00462	CcSEcCtD
Trimethadione—Haemoglobin—Azathioprine—multiple sclerosis	0.000995	0.00447	CcSEcCtD
Trimethadione—Haemorrhage—Azathioprine—multiple sclerosis	0.00099	0.00445	CcSEcCtD
Trimethadione—Ill-defined disorder—Cladribine—multiple sclerosis	0.000983	0.00442	CcSEcCtD
Trimethadione—Headache—Fingolimod—multiple sclerosis	0.000956	0.0043	CcSEcCtD
Trimethadione—Malaise—Cladribine—multiple sclerosis	0.000956	0.0043	CcSEcCtD
Trimethadione—Hiccups—Prednisone—multiple sclerosis	0.00095	0.00427	CcSEcCtD
Trimethadione—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000949	0.00427	CcSEcCtD
Trimethadione—Erythema multiforme—Azathioprine—multiple sclerosis	0.000936	0.00421	CcSEcCtD
Trimethadione—Neutropenia—Mitoxantrone—multiple sclerosis	0.000935	0.0042	CcSEcCtD
Trimethadione—Weight decreased—Mitoxantrone—multiple sclerosis	0.000904	0.00406	CcSEcCtD
Trimethadione—Discomfort—Cladribine—multiple sclerosis	0.000891	0.00401	CcSEcCtD
Trimethadione—Drowsiness—Mitoxantrone—multiple sclerosis	0.000891	0.00401	CcSEcCtD
Trimethadione—Alopecia—Azathioprine—multiple sclerosis	0.000875	0.00393	CcSEcCtD
Trimethadione—Thrombocytopenia—Cladribine—multiple sclerosis	0.000847	0.00381	CcSEcCtD
Trimethadione—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000832	0.00374	CcSEcCtD
Trimethadione—Irritability—Methylprednisolone—multiple sclerosis	0.000831	0.00374	CcSEcCtD
Trimethadione—Anorexia—Cladribine—multiple sclerosis	0.000824	0.00371	CcSEcCtD
Trimethadione—CACNA1G—NCAM1 interactions—PRNP—multiple sclerosis	0.000815	0.0608	CbGpPWpGaD
Trimethadione—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000804	0.00361	CcSEcCtD
Trimethadione—Hepatitis—Mitoxantrone—multiple sclerosis	0.0008	0.0036	CcSEcCtD
Trimethadione—Haemorrhage—Mitoxantrone—multiple sclerosis	0.0008	0.0036	CcSEcCtD
Trimethadione—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000799	0.00359	CcSEcCtD
Trimethadione—Insomnia—Cladribine—multiple sclerosis	0.000782	0.00352	CcSEcCtD
Trimethadione—Malaise—Azathioprine—multiple sclerosis	0.000777	0.00349	CcSEcCtD
Trimethadione—Paraesthesia—Cladribine—multiple sclerosis	0.000777	0.00349	CcSEcCtD
Trimethadione—Leukopenia—Azathioprine—multiple sclerosis	0.000771	0.00347	CcSEcCtD
Trimethadione—Somnolence—Cladribine—multiple sclerosis	0.000769	0.00346	CcSEcCtD
Trimethadione—Irritability—Betamethasone—multiple sclerosis	0.000756	0.0034	CcSEcCtD
Trimethadione—Irritability—Dexamethasone—multiple sclerosis	0.000756	0.0034	CcSEcCtD
Trimethadione—Decreased appetite—Cladribine—multiple sclerosis	0.000752	0.00338	CcSEcCtD
Trimethadione—Fatigue—Cladribine—multiple sclerosis	0.000746	0.00335	CcSEcCtD
Trimethadione—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000745	0.00335	CcSEcCtD
Trimethadione—Discomfort—Azathioprine—multiple sclerosis	0.000725	0.00326	CcSEcCtD
Trimethadione—Feeling abnormal—Cladribine—multiple sclerosis	0.000713	0.0032	CcSEcCtD
Trimethadione—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000707	0.00318	CcSEcCtD
Trimethadione—Alopecia—Mitoxantrone—multiple sclerosis	0.000707	0.00318	CcSEcCtD
Trimethadione—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000689	0.00309	CcSEcCtD
Trimethadione—Abdominal pain—Cladribine—multiple sclerosis	0.000684	0.00307	CcSEcCtD
Trimethadione—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000675	0.00304	CcSEcCtD
Trimethadione—Haemoglobin—Prednisolone—multiple sclerosis	0.00066	0.00297	CcSEcCtD
Trimethadione—Irritability—Prednisone—multiple sclerosis	0.000658	0.00296	CcSEcCtD
Trimethadione—Haemorrhage—Prednisolone—multiple sclerosis	0.000656	0.00295	CcSEcCtD
Trimethadione—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000646	0.0029	CcSEcCtD
Trimethadione—Epistaxis—Triamcinolone—multiple sclerosis	0.000634	0.00285	CcSEcCtD
Trimethadione—Malaise—Mitoxantrone—multiple sclerosis	0.000628	0.00282	CcSEcCtD
Trimethadione—Leukopenia—Mitoxantrone—multiple sclerosis	0.000623	0.0028	CcSEcCtD
Trimethadione—Asthenia—Cladribine—multiple sclerosis	0.000621	0.00279	CcSEcCtD
Trimethadione—Weight decreased—Betamethasone—multiple sclerosis	0.000619	0.00278	CcSEcCtD
Trimethadione—Weight decreased—Dexamethasone—multiple sclerosis	0.000619	0.00278	CcSEcCtD
Trimethadione—Pruritus—Cladribine—multiple sclerosis	0.000612	0.00275	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000611	0.00274	CcSEcCtD
Trimethadione—Haemoglobin—Triamcinolone—multiple sclerosis	0.000607	0.00273	CcSEcCtD
Trimethadione—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000605	0.00272	CcSEcCtD
Trimethadione—Haemorrhage—Triamcinolone—multiple sclerosis	0.000604	0.00271	CcSEcCtD
Trimethadione—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000602	0.00271	CcSEcCtD
Trimethadione—Discomfort—Mitoxantrone—multiple sclerosis	0.000586	0.00263	CcSEcCtD
Trimethadione—Feeling abnormal—Azathioprine—multiple sclerosis	0.000579	0.0026	CcSEcCtD
Trimethadione—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000575	0.00258	CcSEcCtD
Trimethadione—Neutropenia—Prednisone—multiple sclerosis	0.000557	0.0025	CcSEcCtD
Trimethadione—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000557	0.0025	CcSEcCtD
Trimethadione—Abdominal pain—Azathioprine—multiple sclerosis	0.000556	0.0025	CcSEcCtD
Trimethadione—Haemoglobin—Betamethasone—multiple sclerosis	0.000551	0.00247	CcSEcCtD
Trimethadione—Haemoglobin—Dexamethasone—multiple sclerosis	0.000551	0.00247	CcSEcCtD
Trimethadione—Irritability—Methotrexate—multiple sclerosis	0.00055	0.00247	CcSEcCtD
Trimethadione—Vomiting—Cladribine—multiple sclerosis	0.00055	0.00247	CcSEcCtD
Trimethadione—Haemorrhage—Dexamethasone—multiple sclerosis	0.000548	0.00246	CcSEcCtD
Trimethadione—Haemorrhage—Betamethasone—multiple sclerosis	0.000548	0.00246	CcSEcCtD
Trimethadione—Rash—Cladribine—multiple sclerosis	0.000545	0.00245	CcSEcCtD
Trimethadione—Dermatitis—Cladribine—multiple sclerosis	0.000545	0.00245	CcSEcCtD
Trimethadione—Anorexia—Mitoxantrone—multiple sclerosis	0.000542	0.00244	CcSEcCtD
Trimethadione—Headache—Cladribine—multiple sclerosis	0.000542	0.00244	CcSEcCtD
Trimethadione—Weight decreased—Prednisone—multiple sclerosis	0.000539	0.00242	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00053	0.00238	CcSEcCtD
Trimethadione—Malaise—Prednisolone—multiple sclerosis	0.000515	0.00232	CcSEcCtD
Trimethadione—Nausea—Cladribine—multiple sclerosis	0.000514	0.00231	CcSEcCtD
Trimethadione—Vertigo—Prednisolone—multiple sclerosis	0.000513	0.00231	CcSEcCtD
Trimethadione—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00051	0.00229	CcSEcCtD
Trimethadione—Somnolence—Mitoxantrone—multiple sclerosis	0.000505	0.00227	CcSEcCtD
Trimethadione—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000494	0.00222	CcSEcCtD
Trimethadione—Eosinophilia—Methotrexate—multiple sclerosis	0.000493	0.00222	CcSEcCtD
Trimethadione—Fatigue—Mitoxantrone—multiple sclerosis	0.00049	0.0022	CcSEcCtD
Trimethadione—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000488	0.00219	CcSEcCtD
Trimethadione—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000487	0.00219	CcSEcCtD
Trimethadione—Alopecia—Betamethasone—multiple sclerosis	0.000484	0.00218	CcSEcCtD
Trimethadione—Alopecia—Dexamethasone—multiple sclerosis	0.000484	0.00218	CcSEcCtD
Trimethadione—Discomfort—Prednisolone—multiple sclerosis	0.000481	0.00216	CcSEcCtD
Trimethadione—Haemoglobin—Prednisone—multiple sclerosis	0.000479	0.00215	CcSEcCtD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.000479	0.0357	CbGpPWpGaD
Trimethadione—Haemorrhage—Prednisone—multiple sclerosis	0.000477	0.00214	CcSEcCtD
Trimethadione—Malaise—Triamcinolone—multiple sclerosis	0.000474	0.00213	CcSEcCtD
Trimethadione—Pancytopenia—Methotrexate—multiple sclerosis	0.000473	0.00213	CcSEcCtD
Trimethadione—Malaise—Methylprednisolone—multiple sclerosis	0.000473	0.00213	CcSEcCtD
Trimethadione—Vertigo—Triamcinolone—multiple sclerosis	0.000472	0.00212	CcSEcCtD
Trimethadione—Vertigo—Methylprednisolone—multiple sclerosis	0.000471	0.00212	CcSEcCtD
Trimethadione—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000468	0.00211	CcSEcCtD
Trimethadione—Neutropenia—Methotrexate—multiple sclerosis	0.000466	0.00209	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000465	0.00209	CcSEcCtD
Trimethadione—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000449	0.00202	CcSEcCtD
Trimethadione—Vomiting—Azathioprine—multiple sclerosis	0.000447	0.00201	CcSEcCtD
Trimethadione—Drowsiness—Methotrexate—multiple sclerosis	0.000444	0.002	CcSEcCtD
Trimethadione—Rash—Azathioprine—multiple sclerosis	0.000443	0.00199	CcSEcCtD
Trimethadione—Dermatitis—Azathioprine—multiple sclerosis	0.000443	0.00199	CcSEcCtD
Trimethadione—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000442	0.00199	CcSEcCtD
Trimethadione—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000442	0.00199	CcSEcCtD
Trimethadione—Discomfort—Triamcinolone—multiple sclerosis	0.000442	0.00199	CcSEcCtD
Trimethadione—Discomfort—Methylprednisolone—multiple sclerosis	0.000441	0.00198	CcSEcCtD
Trimethadione—Headache—Azathioprine—multiple sclerosis	0.000441	0.00198	CcSEcCtD
Trimethadione—Malaise—Betamethasone—multiple sclerosis	0.00043	0.00193	CcSEcCtD
Trimethadione—Malaise—Dexamethasone—multiple sclerosis	0.00043	0.00193	CcSEcCtD
Trimethadione—Vertigo—Betamethasone—multiple sclerosis	0.000428	0.00193	CcSEcCtD
Trimethadione—Vertigo—Dexamethasone—multiple sclerosis	0.000428	0.00193	CcSEcCtD
Trimethadione—Insomnia—Prednisolone—multiple sclerosis	0.000422	0.0019	CcSEcCtD
Trimethadione—Alopecia—Prednisone—multiple sclerosis	0.000422	0.00189	CcSEcCtD
Trimethadione—Epistaxis—Methotrexate—multiple sclerosis	0.000419	0.00188	CcSEcCtD
Trimethadione—Paraesthesia—Prednisolone—multiple sclerosis	0.000419	0.00188	CcSEcCtD
Trimethadione—Nausea—Azathioprine—multiple sclerosis	0.000418	0.00188	CcSEcCtD
Trimethadione—CACNA1G—Axon guidance—CD24—multiple sclerosis	0.000417	0.0311	CbGpPWpGaD
Trimethadione—Agranulocytosis—Methotrexate—multiple sclerosis	0.000414	0.00186	CcSEcCtD
Trimethadione—Asthenia—Mitoxantrone—multiple sclerosis	0.000408	0.00183	CcSEcCtD
Trimethadione—Discomfort—Betamethasone—multiple sclerosis	0.000401	0.0018	CcSEcCtD
Trimethadione—Discomfort—Dexamethasone—multiple sclerosis	0.000401	0.0018	CcSEcCtD
Trimethadione—Haemoglobin—Methotrexate—multiple sclerosis	0.000401	0.0018	CcSEcCtD
Trimethadione—Haemorrhage—Methotrexate—multiple sclerosis	0.000399	0.00179	CcSEcCtD
Trimethadione—Hepatitis—Methotrexate—multiple sclerosis	0.000399	0.00179	CcSEcCtD
Trimethadione—Insomnia—Triamcinolone—multiple sclerosis	0.000388	0.00174	CcSEcCtD
Trimethadione—Insomnia—Methylprednisolone—multiple sclerosis	0.000387	0.00174	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisone—multiple sclerosis	0.000385	0.00173	CcSEcCtD
Trimethadione—Paraesthesia—Triamcinolone—multiple sclerosis	0.000385	0.00173	CcSEcCtD
Trimethadione—Feeling abnormal—Prednisolone—multiple sclerosis	0.000384	0.00173	CcSEcCtD
Trimethadione—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000384	0.00173	CcSEcCtD
Trimethadione—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000381	0.00171	CcSEcCtD
Trimethadione—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000381	0.00171	CcSEcCtD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000378	0.0282	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000378	0.0282	CbGpPWpGaD
Trimethadione—Erythema multiforme—Methotrexate—multiple sclerosis	0.000377	0.00169	CcSEcCtD
Trimethadione—Malaise—Prednisone—multiple sclerosis	0.000374	0.00168	CcSEcCtD
Trimethadione—Vertigo—Prednisone—multiple sclerosis	0.000373	0.00168	CcSEcCtD
Trimethadione—Anorexia—Dexamethasone—multiple sclerosis	0.000371	0.00167	CcSEcCtD
Trimethadione—Anorexia—Betamethasone—multiple sclerosis	0.000371	0.00167	CcSEcCtD
Trimethadione—Fatigue—Triamcinolone—multiple sclerosis	0.00037	0.00166	CcSEcCtD
Trimethadione—Fatigue—Methylprednisolone—multiple sclerosis	0.000369	0.00166	CcSEcCtD
Trimethadione—Vomiting—Mitoxantrone—multiple sclerosis	0.000361	0.00162	CcSEcCtD
Trimethadione—Rash—Mitoxantrone—multiple sclerosis	0.000358	0.00161	CcSEcCtD
Trimethadione—Dermatitis—Mitoxantrone—multiple sclerosis	0.000358	0.00161	CcSEcCtD
Trimethadione—Headache—Mitoxantrone—multiple sclerosis	0.000356	0.0016	CcSEcCtD
Trimethadione—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000353	0.00159	CcSEcCtD
Trimethadione—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000353	0.00158	CcSEcCtD
Trimethadione—Alopecia—Methotrexate—multiple sclerosis	0.000352	0.00158	CcSEcCtD
Trimethadione—Insomnia—Betamethasone—multiple sclerosis	0.000352	0.00158	CcSEcCtD
Trimethadione—Insomnia—Dexamethasone—multiple sclerosis	0.000352	0.00158	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00035	0.00157	CcSEcCtD
Trimethadione—Paraesthesia—Betamethasone—multiple sclerosis	0.000349	0.00157	CcSEcCtD
Trimethadione—Paraesthesia—Dexamethasone—multiple sclerosis	0.000349	0.00157	CcSEcCtD
Trimethadione—Discomfort—Prednisone—multiple sclerosis	0.000349	0.00157	CcSEcCtD
Trimethadione—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000338	0.00152	CcSEcCtD
Trimethadione—Decreased appetite—Betamethasone—multiple sclerosis	0.000338	0.00152	CcSEcCtD
Trimethadione—Decreased appetite—Dexamethasone—multiple sclerosis	0.000338	0.00152	CcSEcCtD
Trimethadione—Nausea—Mitoxantrone—multiple sclerosis	0.000338	0.00152	CcSEcCtD
Trimethadione—Fatigue—Dexamethasone—multiple sclerosis	0.000336	0.00151	CcSEcCtD
Trimethadione—Fatigue—Betamethasone—multiple sclerosis	0.000336	0.00151	CcSEcCtD
Trimethadione—Anorexia—Prednisone—multiple sclerosis	0.000323	0.00145	CcSEcCtD
Trimethadione—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000322	0.00145	CcSEcCtD
Trimethadione—Feeling abnormal—Betamethasone—multiple sclerosis	0.000321	0.00144	CcSEcCtD
Trimethadione—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000321	0.00144	CcSEcCtD
Trimethadione—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000318	0.00143	CcSEcCtD
Trimethadione—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000318	0.00143	CcSEcCtD
Trimethadione—Malaise—Methotrexate—multiple sclerosis	0.000313	0.00141	CcSEcCtD
Trimethadione—Vertigo—Methotrexate—multiple sclerosis	0.000312	0.0014	CcSEcCtD
Trimethadione—Leukopenia—Methotrexate—multiple sclerosis	0.000311	0.0014	CcSEcCtD
Trimethadione—Asthenia—Triamcinolone—multiple sclerosis	0.000308	0.00138	CcSEcCtD
Trimethadione—Abdominal pain—Dexamethasone—multiple sclerosis	0.000308	0.00138	CcSEcCtD
Trimethadione—Abdominal pain—Betamethasone—multiple sclerosis	0.000308	0.00138	CcSEcCtD
Trimethadione—Asthenia—Methylprednisolone—multiple sclerosis	0.000307	0.00138	CcSEcCtD
Trimethadione—Insomnia—Prednisone—multiple sclerosis	0.000307	0.00138	CcSEcCtD
Trimethadione—Paraesthesia—Prednisone—multiple sclerosis	0.000304	0.00137	CcSEcCtD
Trimethadione—Pruritus—Triamcinolone—multiple sclerosis	0.000303	0.00136	CcSEcCtD
Trimethadione—Pruritus—Methylprednisolone—multiple sclerosis	0.000303	0.00136	CcSEcCtD
Trimethadione—CACNA1G—Developmental Biology—CD24—multiple sclerosis	0.000297	0.0222	CbGpPWpGaD
Trimethadione—Decreased appetite—Prednisone—multiple sclerosis	0.000295	0.00132	CcSEcCtD
Trimethadione—Rash—Prednisolone—multiple sclerosis	0.000294	0.00132	CcSEcCtD
Trimethadione—Dermatitis—Prednisolone—multiple sclerosis	0.000294	0.00132	CcSEcCtD
Trimethadione—Fatigue—Prednisone—multiple sclerosis	0.000292	0.00131	CcSEcCtD
Trimethadione—Headache—Prednisolone—multiple sclerosis	0.000292	0.00131	CcSEcCtD
Trimethadione—Discomfort—Methotrexate—multiple sclerosis	0.000292	0.00131	CcSEcCtD
Trimethadione—Feeling abnormal—Prednisone—multiple sclerosis	0.000279	0.00126	CcSEcCtD
Trimethadione—Asthenia—Dexamethasone—multiple sclerosis	0.000279	0.00125	CcSEcCtD
Trimethadione—Asthenia—Betamethasone—multiple sclerosis	0.000279	0.00125	CcSEcCtD
Trimethadione—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000277	0.00125	CcSEcCtD
Trimethadione—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000277	0.00125	CcSEcCtD
Trimethadione—Nausea—Prednisolone—multiple sclerosis	0.000277	0.00125	CcSEcCtD
Trimethadione—Pruritus—Dexamethasone—multiple sclerosis	0.000275	0.00124	CcSEcCtD
Trimethadione—Pruritus—Betamethasone—multiple sclerosis	0.000275	0.00124	CcSEcCtD
Trimethadione—Vomiting—Triamcinolone—multiple sclerosis	0.000273	0.00123	CcSEcCtD
Trimethadione—Vomiting—Methylprednisolone—multiple sclerosis	0.000272	0.00122	CcSEcCtD
Trimethadione—Rash—Triamcinolone—multiple sclerosis	0.00027	0.00122	CcSEcCtD
Trimethadione—Dermatitis—Triamcinolone—multiple sclerosis	0.00027	0.00121	CcSEcCtD
Trimethadione—Anorexia—Methotrexate—multiple sclerosis	0.00027	0.00121	CcSEcCtD
Trimethadione—Rash—Methylprednisolone—multiple sclerosis	0.00027	0.00121	CcSEcCtD
Trimethadione—Dermatitis—Methylprednisolone—multiple sclerosis	0.00027	0.00121	CcSEcCtD
Trimethadione—Headache—Triamcinolone—multiple sclerosis	0.000269	0.00121	CcSEcCtD
Trimethadione—Headache—Methylprednisolone—multiple sclerosis	0.000268	0.0012	CcSEcCtD
Trimethadione—Abdominal pain—Prednisone—multiple sclerosis	0.000268	0.0012	CcSEcCtD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000266	0.0198	CbGpPWpGaD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000266	0.0198	CbGpPWpGaD
Trimethadione—Insomnia—Methotrexate—multiple sclerosis	0.000256	0.00115	CcSEcCtD
Trimethadione—Nausea—Triamcinolone—multiple sclerosis	0.000255	0.00114	CcSEcCtD
Trimethadione—Paraesthesia—Methotrexate—multiple sclerosis	0.000254	0.00114	CcSEcCtD
Trimethadione—Nausea—Methylprednisolone—multiple sclerosis	0.000254	0.00114	CcSEcCtD
Trimethadione—Somnolence—Methotrexate—multiple sclerosis	0.000252	0.00113	CcSEcCtD
Trimethadione—Vomiting—Dexamethasone—multiple sclerosis	0.000247	0.00111	CcSEcCtD
Trimethadione—Vomiting—Betamethasone—multiple sclerosis	0.000247	0.00111	CcSEcCtD
Trimethadione—Decreased appetite—Methotrexate—multiple sclerosis	0.000246	0.00111	CcSEcCtD
Trimethadione—Rash—Dexamethasone—multiple sclerosis	0.000245	0.0011	CcSEcCtD
Trimethadione—Rash—Betamethasone—multiple sclerosis	0.000245	0.0011	CcSEcCtD
Trimethadione—Dermatitis—Betamethasone—multiple sclerosis	0.000245	0.0011	CcSEcCtD
Trimethadione—Dermatitis—Dexamethasone—multiple sclerosis	0.000245	0.0011	CcSEcCtD
Trimethadione—Fatigue—Methotrexate—multiple sclerosis	0.000244	0.0011	CcSEcCtD
Trimethadione—Headache—Betamethasone—multiple sclerosis	0.000244	0.0011	CcSEcCtD
Trimethadione—Headache—Dexamethasone—multiple sclerosis	0.000244	0.0011	CcSEcCtD
Trimethadione—Asthenia—Prednisone—multiple sclerosis	0.000243	0.00109	CcSEcCtD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00024	0.0179	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00024	0.0179	CbGpPWpGaD
Trimethadione—Pruritus—Prednisone—multiple sclerosis	0.00024	0.00108	CcSEcCtD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000237	0.0176	CbGpPWpGaD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000237	0.0176	CbGpPWpGaD
Trimethadione—Feeling abnormal—Methotrexate—multiple sclerosis	0.000233	0.00105	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000232	0.00104	CcSEcCtD
Trimethadione—Nausea—Betamethasone—multiple sclerosis	0.000231	0.00104	CcSEcCtD
Trimethadione—Nausea—Dexamethasone—multiple sclerosis	0.000231	0.00104	CcSEcCtD
Trimethadione—Abdominal pain—Methotrexate—multiple sclerosis	0.000224	0.00101	CcSEcCtD
Trimethadione—Vomiting—Prednisone—multiple sclerosis	0.000215	0.000968	CcSEcCtD
Trimethadione—Rash—Prednisone—multiple sclerosis	0.000214	0.00096	CcSEcCtD
Trimethadione—Dermatitis—Prednisone—multiple sclerosis	0.000213	0.00096	CcSEcCtD
Trimethadione—Headache—Prednisone—multiple sclerosis	0.000212	0.000954	CcSEcCtD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000207	0.0155	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000207	0.0155	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000205	0.0152	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000205	0.0152	CbGpPWpGaD
Trimethadione—Asthenia—Methotrexate—multiple sclerosis	0.000203	0.000913	CcSEcCtD
Trimethadione—Nausea—Prednisone—multiple sclerosis	0.000201	0.000905	CcSEcCtD
Trimethadione—Pruritus—Methotrexate—multiple sclerosis	0.0002	0.000901	CcSEcCtD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000194	0.0145	CbGpPWpGaD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000194	0.0145	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000185	0.0138	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000185	0.0138	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000183	0.0136	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000183	0.0136	CbGpPWpGaD
Trimethadione—Vomiting—Methotrexate—multiple sclerosis	0.00018	0.000809	CcSEcCtD
Trimethadione—Rash—Methotrexate—multiple sclerosis	0.000179	0.000803	CcSEcCtD
Trimethadione—Dermatitis—Methotrexate—multiple sclerosis	0.000178	0.000802	CcSEcCtD
Trimethadione—Headache—Methotrexate—multiple sclerosis	0.000177	0.000797	CcSEcCtD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000175	0.0131	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000175	0.0131	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000169	0.0126	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000169	0.0126	CbGpPWpGaD
Trimethadione—Nausea—Methotrexate—multiple sclerosis	0.000168	0.000756	CcSEcCtD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000168	0.0125	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000168	0.0125	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000167	0.0124	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000167	0.0124	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000167	0.0124	CbGpPWpGaD
Trimethadione—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000155	0.0116	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00015	0.0112	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00015	0.0112	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—PRNP—multiple sclerosis	0.000137	0.0102	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000137	0.0102	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000137	0.0102	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000124	0.00921	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	0.000115	0.00859	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000111	0.00829	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000111	0.00829	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00011	0.00818	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00011	0.00818	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—PTPRC—multiple sclerosis	0.000107	0.00797	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000106	0.00791	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000103	0.0077	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000103	0.0077	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000102	0.00759	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000102	0.00759	CbGpPWpGaD
Trimethadione—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	9.98e-05	0.00744	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—PRNP—multiple sclerosis	9.81e-05	0.00731	CbGpPWpGaD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	9.53e-05	0.0071	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.02e-05	0.00672	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.02e-05	0.00672	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	8.93e-05	0.00665	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	8.93e-05	0.00665	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.8e-05	0.00656	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.8e-05	0.00656	CbGpPWpGaD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.7e-05	0.00648	CbGpPWpGaD
Trimethadione—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.67e-05	0.00646	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	8.16e-05	0.00608	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	7.97e-05	0.00594	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	7.97e-05	0.00594	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.86e-05	0.00586	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.86e-05	0.00586	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—PTPRC—multiple sclerosis	7.63e-05	0.00568	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	7.27e-05	0.00541	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	7.27e-05	0.00541	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.17e-05	0.00534	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.17e-05	0.00534	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.73e-05	0.00427	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.4e-05	0.00402	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.79e-05	0.00357	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.79e-05	0.00357	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—TYK2—multiple sclerosis	4.78e-05	0.00356	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.73e-05	0.00352	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.73e-05	0.00352	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.66e-05	0.00348	CbGpPWpGaD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.37e-05	0.00326	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.16e-05	0.0031	CbGpPWpGaD
Trimethadione—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	3.98e-05	0.00297	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.8e-05	0.00283	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.78e-05	0.00282	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MMP9—multiple sclerosis	3.77e-05	0.00281	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.43e-05	0.00255	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.43e-05	0.00255	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TYK2—multiple sclerosis	3.41e-05	0.00254	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.37e-05	0.00251	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.08e-05	0.00229	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.06e-05	0.00228	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.06e-05	0.00228	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK1—multiple sclerosis	3.04e-05	0.00227	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.79e-05	0.00208	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.79e-05	0.00208	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MMP9—multiple sclerosis	2.69e-05	0.002	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SRM—multiple sclerosis	2.51e-05	0.00187	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.5e-05	0.00187	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—STAT3—multiple sclerosis	2.39e-05	0.00178	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—IL6—multiple sclerosis	2.34e-05	0.00174	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—POMC—multiple sclerosis	2.32e-05	0.00173	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TGFB1—multiple sclerosis	2.22e-05	0.00165	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK1—multiple sclerosis	2.17e-05	0.00162	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SRM—multiple sclerosis	2.17e-05	0.00161	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TNF—multiple sclerosis	2.07e-05	0.00154	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.03e-05	0.00151	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.01e-05	0.0015	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SRM—multiple sclerosis	1.93e-05	0.00144	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.79e-05	0.00134	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	1.77e-05	0.00132	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	1.77e-05	0.00132	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SRM—multiple sclerosis	1.76e-05	0.00131	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—IL6—multiple sclerosis	1.67e-05	0.00124	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.63e-05	0.00122	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.62e-05	0.0012	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.53e-05	0.00114	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.53e-05	0.00114	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.49e-05	0.00111	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.4e-05	0.00104	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.36e-05	0.00102	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.36e-05	0.00102	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.000998	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.33e-05	0.000993	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000929	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.24e-05	0.000926	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.24e-05	0.000926	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.21e-05	0.000905	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SRM—multiple sclerosis	1.16e-05	0.000867	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.16e-05	0.000862	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.14e-05	0.000847	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.08e-05	0.000803	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.03e-05	0.00077	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.42e-06	0.000702	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.98e-06	0.000669	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.19e-06	0.000611	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.19e-06	0.000611	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.01e-06	0.000597	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.71e-06	0.000575	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—BCHE—multiple sclerosis	7.69e-06	0.000573	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.49e-06	0.000559	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.31e-06	0.000544	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.03e-06	0.000524	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.88e-06	0.000513	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.65e-06	0.000495	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.28e-06	0.000468	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.28e-06	0.000468	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.21e-06	0.000463	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.93e-06	0.000442	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.72e-06	0.000426	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.41e-06	0.000403	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—APOE—multiple sclerosis	4.63e-06	0.000345	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—APOE—multiple sclerosis	4e-06	0.000298	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—POMC—multiple sclerosis	3.97e-06	0.000296	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ALB—multiple sclerosis	3.62e-06	0.00027	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—APOE—multiple sclerosis	3.57e-06	0.000266	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.57e-06	0.000266	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—POMC—multiple sclerosis	3.43e-06	0.000256	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—APOE—multiple sclerosis	3.25e-06	0.000242	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ALB—multiple sclerosis	3.13e-06	0.000233	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—POMC—multiple sclerosis	3.07e-06	0.000228	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—POMC—multiple sclerosis	2.8e-06	0.000208	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ALB—multiple sclerosis	2.79e-06	0.000208	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ALB—multiple sclerosis	2.55e-06	0.00019	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—APOE—multiple sclerosis	2.15e-06	0.00016	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—POMC—multiple sclerosis	1.84e-06	0.000137	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ALB—multiple sclerosis	1.68e-06	0.000125	CbGpPWpGaD
